ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

Addition of Ianalumab (VAY736) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia on Ibrutinib Therapy: Results from a Phase Ib Study.

Kerry A Rogers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.